草药化合物的保护作用,防止循环胺诱导的器官毒性:以途径为中心的方法
Prathap Srirangan1, Evan Prince Sabina1
1Department of Biotechnology, School of Biosciences and Technology, VIT University, Vellore, India.
Drug and chemical toxicology
|January 23, 2025
概括
环胺 (CPM) 有效治疗各种疾病,但会导致器官损伤. 像黄素这样的草药化合物显示出降低CPM毒性的前景,突出了对自然疗法的临床试验的需要.
科学领域:
- 药理学 药理学是指药理学的学科.
- 毒理学 毒理学 毒理学
- 自然产品化学 自然产品化学
背景情况:
- 环胺 (CPM) 是一种广泛使用的化疗剂,具有广泛的疗效.
- 治疗CPM与严重的剂量依赖性器官毒性有关,影响脏,肝脏,心脏,肺部和肠道.
- 了解CPM的代谢途径和毒性机制对于改善患者的治疗结果至关重要.
研究的目的:
- 审查循环胺 (CPM) 的代谢途径,治疗用途和器官特异性毒性.
- 探索CPM引起的器官损伤背后的分子机制.
- 识别和评估草药和植物化学品在缓解CPM毒性的潜力.
主要方法:
- 对循环胺 (CPM) 代谢,疗效和毒性研究的文献综述.
- 对参与CPM诱导器官损伤的分子途径的分析,包括Nrf2,NF-κB,MAPK/ERK和AKT.
- 汇编和评估关于植物化学物质 (例如,肉甲,贝卡林,奎尔,黄素) 的研究,这些植物化学物质对CPM毒性具有保护作用.
主要成果:
- 环胺 (CPM) 具有显著的治疗效益,但会引起严重的器官毒性.
- CPM毒性的分子机制涉及关键信号通路的失调,亡和炎症.
- 一些植物化学物质通过恢复信号通路和生物标志物来减轻CPM诱导的器官损伤的潜力.
结论:
- 草药和植物化学品在降低环胺 (CPM) 毒性方面表现有希望,可能提高治疗的安全性和有效性.
- 进一步的体内和临床研究对于验证这些天然化合物的有效性和安全性至关重要.
- 将植物化学物质整合到治疗方案中可以改善CPM治疗患者的患者结果.
相关概念视频
Drug Distribution: Tissue Binding
2.5K
Upon entering the systemic circulation, drugs can distribute into the interstitial and intracellular fluid of various tissue cells. This distribution is facilitated by the binding of drugs to different cellular components within tissues, which may lead to drug accumulation in specific areas. Drugs bound to tissue components serve as reservoirs that release free drugs back into the system, prolonging the drug's overall action. However, this accumulation can also result in local toxicity.
For...
For...
2.5K
Hepatic Drug Excretion: Enterohepatic Cycling
963
Enterohepatic cycling involves the active secretion of drugs and their metabolites into the bile via transporters in the canalicular membrane of hepatocytes. This secretion is an integral part of the digestive process, releasing these substances into the gastrointestinal (GI) tract.
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
Post-release drugs and metabolites can be reabsorbed into the body from the intestine. For conjugated metabolites like glucuronides, reabsorption requires enzymatic hydrolysis by intestinal microflora. This...
963
Enhanced Elimination of Poison
470
Poison can be effectively removed from the gastrointestinal (GI) tract through various decontamination procedures.
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
Antidotes serve a crucial role in counteracting the effects of poison by inhibiting enzymes responsible for producing harmful drug metabolites. In some cases, these toxic metabolites can be neutralized by endogenous cosubstrates, which are maintained at specific concentrations to prevent interaction with cellular macromolecules and subsequent cell death.
Renal excretion is the...
470
Combined Effects of Drugs: Synergism
3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
3.7K
Effects of Chemicals: Overview
1.2K
Drugs, encompassing various chemical compounds from natural sources, lab synthesis, or genetic engineering, elicit different biological responses in living organisms. Some of these responses are desirable or therapeutic, while others are undesirable. The primary goal of administering a drug is to achieve a therapeutic effect, that is, to address a specific disease or health condition. Any concurrent effects outside of this therapeutic outcome are considered undesirable. These undesirable...
1.2K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141


